Table 3. Practitioners’ comfort in implementing the renewed program in the pre- and post-renewal samples^*.

Key components	Questions/indicators	Pre-renewal		Post-renewal		Crude RR (95% CI)	P-value	Adjusted RR (95% CI)	P-value
		n	%	n	%
Age and interval	1. Only offering routine cervical screening to women 25 years and over	108/156	69.2	151/175	86.3	1.25 (1.11 to 1.41)	<0.001	1.20 (1.06 to 1.36)	0.005α
	2. Screening HPV negative women every 5 years	131/157	83.4	159/175	91.0	1.09 (1.00 to 1.19)	0.04	1.05 (0.96 to 1.15)	0.26β
Sample collection	3. Collecting only a liquid based sample (not preparing a slide)	139/157	88.5	158/174	91.0	1.03 (0.95 to 1.10)	0.50	1.02 (0.95 to 1.10)	0.57£
Referral pathways	4. Referring all HPV16/18 positive women for colposcopy regardless of their cytology result	117/153	76.5	148/175	84.6	1.11 (0.99 to 1.23)	0.06	1.09 (0.99 to 1.21)	0.08£
	5. Not referring women with oncogenic HPV non 16/18positive tests who have low grade/negative cytology for colposcopy	63/152	41.4	108/173	62.4	1.51 (1.21 to 1.88)	<0.001	1.35 (1.10 to 1.69)	0.01Ψ
Self-collection	6. Recommending self-collection to an under-screened woman who refuses a practitioner-collected cervical sample	73/156	46.8	101/176	57.4	1.23 (0.99 to 1.51)	0.05	1.09 (0.87 to 1.37)	0.44€
	7. Having to wait to offer a repeat self-collection until the woman is overdue again (7 years since last screen)	29/152	19.1	53/175	30.2	1.59 (1.07 to 2.36)	0.023	1.30 (0.86 to 1.97)	0.21α

* Non responders removed from each item denominator

α Adjusted for place of practice

β Adjusted for place of practice, role and years in practice

£ Adjusted for role and years in practice

Ψ Adjusted for place of practice and role in practice

€ Adjusted for place of practice and an interaction between the renewal time period and place of practice (p = 0.045).